Deetya Onkar Leak Fix Now

Founded in 2021 by former Stanford neuroscientists and Dr. Onkar Patel , DOL positioned itself as “the next generation of personalized medicine.” Their flagship product— NeuroPulse , an AI‑powered platform that analyzes EEG and wearable sensor data to predict neurological disorders—raised $210 M in Series C funding (2024) and secured a partnership with three major hospital networks.